Autopsy report · NCT03134638
A Study of SY-1365 in Adult Patients With Advanced Solid Tumors
Cause of deathFunding or business
“Business Decision”
Life of this trial
- Ran for about 3 years 1 month before it stopped.
- 107 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Syros Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Advanced Solid Tumors; Ovarian Cancer; Breast Cancer
- Interventions
- SY-1365 (Part 1); Carboplatin; Fulvestrant; SY-1365 (Cohort 2); SY-1365 (Cohort 5); SY-1365 (Part 2 Single Agent)
- Participants
- 107
- Sites
- 20
- Countries
- Canada, France, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.